Literature DB >> 15967985

Regulation of dopaminergic transmission and cocaine reward by the Clock gene.

Colleen A McClung1, Kyriaki Sidiropoulou, Martha Vitaterna, Joseph S Takahashi, Francis J White, Donald C Cooper, Eric J Nestler.   

Abstract

Although there are clear interactions between circadian rhythms and drug addiction, mechanisms for such interactions remain unknown. Here we establish a role for the Clock gene in regulating the brain's reward circuit. Mice lacking a functional Clock gene display an increase in cocaine reward and in the excitability of dopamine neurons in the midbrain ventral tegmental area, a key brain reward region. These phenotypes are associated with increased expression and phosphorylation of tyrosine hydroxylase (the rate-limiting enzyme in dopamine synthesis), as well as changes in several genes known to regulate dopamine activity in the ventral tegmental area. These findings demonstrate the involvement of a circadian-associated gene, Clock, in regulating dopamine function and cocaine reward.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15967985      PMCID: PMC1166621          DOI: 10.1073/pnas.0503584102

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

Review 1.  Molecular analysis of mammalian circadian rhythms.

Authors:  S M Reppert; D R Weaver
Journal:  Annu Rev Physiol       Date:  2001       Impact factor: 19.318

2.  Drugs of abuse and stress trigger a common synaptic adaptation in dopamine neurons.

Authors:  Daniel Saal; Yan Dong; Antonello Bonci; Robert C Malenka
Journal:  Neuron       Date:  2003-02-20       Impact factor: 17.173

Review 3.  Elevated levels of GluR1 in the midbrain: a trigger for sensitization to drugs of abuse?

Authors:  William A Carlezon; Eric J Nestler
Journal:  Trends Neurosci       Date:  2002-12       Impact factor: 13.837

Review 4.  KCNQ potassium channels: physiology, pathophysiology, and pharmacology.

Authors:  J Robbins
Journal:  Pharmacol Ther       Date:  2001-04       Impact factor: 12.310

5.  Enhanced vulnerability to cocaine self-administration is associated with elevated impulse activity of midbrain dopamine neurons.

Authors:  M Marinelli; F J White
Journal:  J Neurosci       Date:  2000-12-01       Impact factor: 6.167

6.  Characterization of cocaine self-administration and pharmacokinetics as a function of time of day in the rat.

Authors:  T J Baird; D Gauvin
Journal:  Pharmacol Biochem Behav       Date:  2000-02       Impact factor: 3.533

7.  The effects of cocaine on mood and sleep in cocaine-dependent males.

Authors:  C E Johanson; T Roehrs; K Schuh; L Warbasse
Journal:  Exp Clin Psychopharmacol       Date:  1999-11       Impact factor: 3.157

8.  Patterns of cocaine self-administration in rats produced by various access conditions under a discrete trials procedure.

Authors:  David C S Roberts; Karen Brebner; Michelle Vincler; Wendy J Lynch
Journal:  Drug Alcohol Depend       Date:  2002-08-01       Impact factor: 4.492

Review 9.  The significance of action potential bursting in the brain reward circuit.

Authors:  Donald C Cooper
Journal:  Neurochem Int       Date:  2002-11       Impact factor: 3.921

10.  Cocaine sensitization and reward are under the influence of circadian genes and rhythm.

Authors:  Carolina Abarca; Urs Albrecht; Rainer Spanagel
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-25       Impact factor: 11.205

View more
  209 in total

Review 1.  The role of sleep problems and circadian clock genes in childhood psychiatric disorders.

Authors:  Alexander Dueck; Johannes Thome; Frank Haessler
Journal:  J Neural Transm (Vienna)       Date:  2012-06-06       Impact factor: 3.575

Review 2.  Common cellular and molecular mechanisms in obesity and drug addiction.

Authors:  Paul J Kenny
Journal:  Nat Rev Neurosci       Date:  2011-10-20       Impact factor: 34.870

3.  Intrathecal cocaine delivery enables long-access self-administration with binge-like behavior in mice.

Authors:  Masato Nakamura; Shuibo Gao; Hitoshi Okamura; Daiichiro Nakahara
Journal:  Psychopharmacology (Berl)       Date:  2010-09-23       Impact factor: 4.530

Review 4.  Circadian rhythms and mood regulation: insights from pre-clinical models.

Authors:  Colleen A McClung
Journal:  Eur Neuropsychopharmacol       Date:  2011-08-11       Impact factor: 4.600

5.  Cell-Type-Specific Regulation of Nucleus Accumbens Synaptic Plasticity and Cocaine Reward Sensitivity by the Circadian Protein, NPAS2.

Authors:  Puja K Parekh; Ryan W Logan; Kyle D Ketchesin; Darius Becker-Krail; Micah A Shelton; Mariah A Hildebrand; Kelly Barko; Yanhua H Huang; Colleen A McClung
Journal:  J Neurosci       Date:  2019-04-08       Impact factor: 6.167

Review 6.  Establishing a framework for neuropathological correlates and glymphatic system functioning in Parkinson's disease.

Authors:  Saranya Sundaram; Rachel L Hughes; Eric Peterson; Eva M Müller-Oehring; Helen M Brontë-Stewart; Kathleen L Poston; Afik Faerman; Chloe Bhowmick; Tilman Schulte
Journal:  Neurosci Biobehav Rev       Date:  2019-05-24       Impact factor: 8.989

Review 7.  Animal models of bipolar mania: The past, present and future.

Authors:  R W Logan; C A McClung
Journal:  Neuroscience       Date:  2015-08-24       Impact factor: 3.590

8.  Time of day regulates subcellular trafficking, tripartite synaptic localization, and polyadenylation of the astrocytic Fabp7 mRNA.

Authors:  Jason R Gerstner; William M Vanderheyden; Timothy LaVaute; Cara J Westmark; Labib Rouhana; Allan I Pack; Marv Wickens; Charles F Landry
Journal:  J Neurosci       Date:  2012-01-25       Impact factor: 6.167

9.  Photoperiodic suppression of drug reinstatement.

Authors:  B A Sorg; G Stark; A Sergeeva; H T Jansen
Journal:  Neuroscience       Date:  2010-12-24       Impact factor: 3.590

10.  Circadian genes Period 1 and Period 2 in the nucleus accumbens regulate anxiety-related behavior.

Authors:  Sade Spencer; Edgardo Falcon; Jaswinder Kumar; Vaishnav Krishnan; Shibani Mukherjee; Shari G Birnbaum; Colleen A McClung
Journal:  Eur J Neurosci       Date:  2012-10-08       Impact factor: 3.386

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.